Invibragen focuses on enabling high-throughput molecular analysis and advancing cutting-edge research in ionization sensitivity, ion source utility, and emerging analytical applications. The company's Spanda platform is backed by peer-reviewed research and supported by federal research funding, including multiple awards from the U.S. National Science Foundation and National Institutes of Health.

Invibragen is led by Professor Stephen Valentine and Professor Peng Li, experts in bioanalytical chemistry and instrumentation, together with a multidisciplinary team working at the intersection of analytical chemistry, mass spectrometry, and applied research.